Disease

Susceptibility to atypical hemolytic uremic syndrome- 41, 2

Gene

CFB

Inheritance AD
Current Treatments Eculizumab, Ravulizumab, Plasma infusion or exchange
Evidence for Treatment guideline3
Non-Molecular Testing Availability no
Disease Frequency (per 100,000) 0.24
Genes Included in Disease Frequency C3, CFH, CFI, THBD, CD46, CFB, CFHR1
Experimental / Investigational Therapies https://clinicaltrials.gov/ct2/results?cond=Atypical+Hemolytic+Uremic+Syndrome&term=&cntry=&state=&city=&dist=
Last Updated: March 5, 2026
RX Genes
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.